Abstract:figure legend Auditory outer hair cells are the cochlear amplifier essential for normal hearing sensitivity and frequency selectivity. This study used both cell lines and a mouse model to define the pathogenic role of compound heterozygous p.W70X (c.209G>A) and p.R130S (c.390A>C) SLC26A5 variants identified in patients with moderate to profound hearing loss. We found that the p.W70X nonsense variant results in a null prestin allele, and that mice carrying one copy of p.R130S (Slc26a5R130S/‐) as in human patients (SLC26A5W70X/R130S) suffer from congenital hearing loss and subsequent premature outer hair cell loss. The latter are both ascribed to slowed motor function of p.R130S prestin, as demonstrated in our preceding studies. Given the recessive nature of prestin‐associated hearing loss, DFNB61, this study points to the presence of a therapeutic time window for potential clinical interventions targeting the affected OHCs before they are lost. DFNB61 is a recessively inherited nonsyndromic hearing loss caused by mutations in SLC26A5, the gene that encodes the voltage‐driven motor protein, prestin. Prestin is abundantly expressed in the auditory outer hair cells that mediate cochlear amplification. Two DFNB61‐associated SLC26A5 variants, p.W70X and p.R130S, were identified in patients who are compound heterozygous for these nonsense and missense changes (SLC26A5W70X/R130S). Our recent study showed that mice homozygous for p.R130S (Slc26a5R130S/R130S) suffer from hearing loss that is ascribed to significantly reduced motor kinetics of prestin. Given that W70X‐prestin is nonfunctional, compound heterozygous Slc26a5R130S/− mice were used as a model for human SLC26A5W70X/R130S. By examining the pathophysiological consequences of p.R130S prestin when it is the sole allele for prestin protein production, we determined that this missense change results in progressive outer hair cell loss in addition to its effects on prestin's motor action. Thus, this study defines the pathogenic roles of p.R130S prestin and identifies a limited time window for potential clinical intervention. Key points The voltage‐driven motor protein, prestin, is encoded by SLC26A5 and expressed abundantly in cochlear outer hair cells (OHCs). The importance of prestin for normal hearing was demonstrated in mice lacking prestin; however, none of the specific SLC26A5 variants identified to date in human patients has been experimentally demonstrated to be pathogenic. In this study we used both cell lines and a mouse model to define the pathogenic role of compound heterozygous p.W70X (c.209G>A) and p.R130S (c.390A>C) SLC26A5 variants identified in patients with moderate to profound hearing loss. As in patients, mice carrying one copy of p.R130S Slc26a5 showed OHC dysfunction and progressive degeneration, which results in congenital progressive hearing loss. This is the first functional study reporting pathogenic SLC26A5 variants and pointing to the presence of a therapeutic time window for potential clinical interventions targeting the affected OHCs before they are lost.

Hearing Loss Andprps1mutations: Wide Spectrum of Phenotypes and Potential Therapy

Loss-of-function mutations in the PRPS1 gene cause a type of nonsyndromic X-linked sensorineural deafness, DFN2.

Phosphoribosylpyrophosphate synthetase superactivity and recurrent infections is caused by a p.Val142Leu mutation in PRS-I

Defects in Mitochondrial Ribosomal Biogenesis Cause Sensorineural Deafness

Mutations of Human NARS2, Encoding the Mitochondrial Asparaginyl-Trna Synthetase, Cause Nonsyndromic Deafness and Leigh Syndrome

Functional Characterization of the Mitochondrial 12S Rrna C1494T Mutation Associated with Aminoglycoside-Induced and Non-Syndromic Hearing Loss.

Molecular analysis of the mitochondrial 12S rRNA and tRNASer(UCN) genes in paediatric subjects with non-syndromic hearing loss.

[Modifier Factors Influencing the Phenotypic Manifestation of the Deafness Associated Mitochondrial DNA Mutations].

A Dominant Variant in the PDE1C Gene is Associated with Nonsyndromic Hearing Loss

Delayed Progressive Sensorineural Hearing Loss Due to a Novel Compound Heterozygous PTPRQ Mutation in a Chinese Patient

Clinical characteristics and genetics of ten Chinese children with PRRT2-associated neurological diseases

S1PR2 Variants Associated with Auditory Function in Humans and Endocochlear Potential Decline in Mouse

A Novel PTPRQ c.3697del Variant Causes Autosomal Dominant Progressive Hearing Loss in Both Humans and Mice

Mutation of the Atp-Gated P2x(2) Receptor Leads to Progressive Hearing Loss and Increased Susceptibility to Noise

A Novel Mutation in PRPS1 Causes X‐linked Charcot‐Marie‐Tooth Disease‐5

Autosomal Recessive Congenital Sensorineural Hearing Loss Due to a Novel Compound Heterozygous PTPRQ Mutation in a Chinese Family

Mutation of SLC7A14 causes auditory neuropathy and retinitis pigmentosa mediated by lysosomal dysfunction

New Insight into the Genotype-Phenotype Correlation of <i>PRPH2</i>-Related Diseases Based on a Large Chinese Cohort and Literature Review

An Integrated Genetic and Functional Analysis of the Role of Type II Transmembrane Serine Proteases (tmprsss) in Hearing Loss.

The pathogenic roles of the p.R130S prestin variant in DFNB61 hearing loss

Mutation spectrum of PRPF31, genotype-phenotype correlation in retinitis pigmentosa, and opportunities for therapy